| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $797K | — |
| R&D Expense | $1.8M | +19.3% |
| SG&A Expense | $3.8M | +5.0% |
| Operating Income | -$4.8M | +5.7% |
| Interest Expense | $224K | -71.2% |
| Pre-tax Income | -$3.5M | +32.7% |
| Income Tax | $0 | — |
| Net Income | -$3.4M | +34.0% |
| EPS (Diluted) | -$0.19 | +61.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $253K | — |
| Inventory | $143K | — |
| Current Assets | $814K | +590.3% |
| Total Assets | $2.1M | +456.4% |
| Current Liabilities | $8.3M | +1.2% |
| Total Liabilities | $13.7M | +7.3% |
| Stockholders' Equity | -$11.2M | +7.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | -109.6% |
| Financing Cash Flow | $2.3M | +110.0% |